EUVIMEDEUVIMED entdecken
Crossref

C1q enables influenza hemagglutinin stem binding antibodies to block viral attachment and broadens the antibody escape repertoire

Ivan Kosik iD, Jefferson Da Silva Santos iD, Mathew Angel, Zhe Hu, Jaroslav Holly iD, James S Gibbs, Tanner Gill iD, Martina Kosikova, Tiansheng Li, William Bakhache iD, Patrick T Dolan iD, Hang Xie iD und 6 weitere

Science Immunology · 22.03.2024 · 9 (93)

DOI: 10.1126/sciimmunol.adj9534 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Immunology, erschienen am 22.03.2024. Verfasst von Ivan Kosik und 17 weiteren Autor:innen. Beteiligte Einrichtung: Cellular Biology Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA. Hauptthemen laut MEDLINE: Influenza, Human, Influenza Vaccines. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 70 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antigenic drift, the gradual accumulation of amino acid substitutions in the influenza virus hemagglutinin (HA) receptor protein, enables viral immune evasion. Antibodies (Abs) specific for the drift-resistant HA stem region are a promising universal influenza vaccine target. Although anti-stem Abs are not believed to block viral attachment, here we show that complement component 1q (C1q), a 460-kilodalton protein with six Ab Fc-binding domains, confers attachment inhibition to anti-stem Abs and enhances their fusion and neuraminidase inhibition. As a result, virus neutralization activity in vitro is boosted up to 30-fold, and in vivo protection from influenza PR8 infection in mice is enhanced. These effects reflect increased steric hindrance and not increased Ab avidity. C1q greatly expands the anti-stem Ab viral escape repertoire to include residues throughout the HA, some of which cause antigenic alterations in the globular region or modulate HA receptor avidity. We also show that C1q enhances the neutralization activity of non–receptor binding domain anti–SARS-CoV-2 spike Abs, an effect dependent on spike density on the virion surface. These findings demonstrate that C1q can greatly expand Ab function and thereby contribute to viral evolution and immune escape.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Influenza, HumanInfluenza VaccinesMiceAnimalsHumansHemagglutininsComplement C1qVirus AttachmentHemagglutinin Glycoproteins, Influenza VirusAntibodies, Viral

Substanzen

HemagglutininsComplement C1qHemagglutinin Glycoproteins, Influenza VirusAntibodies, ViralInfluenza Vaccines

Autor:innen und Institutionen

  • Cellular Biology Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
  • Laboratory of Respiratory Viral Diseases, Division of Viral Products, Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA.
  • Quantitative Virology and Evolution Unit, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
  • Vaccine Immunology Program, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Molecular Immunoengineering Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Viral Pathogenesis Section, Laboratory of Viral Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.

ORCID-Profile: Ivan Kosik, Jefferson Da Silva Santos, Jaroslav Holly, Tanner Gill, William Bakhache, Patrick T Dolan, Hang Xie, Sarah F Andrews, Rebecca A Gillespie, Masaru Kanekiyo, Adrian B McDermott, Theodore C Pierson, Jonathan W Yewdell

Zitieren

APA

Kosik, I., Da Silva Santos, J., Angel, M., Hu, Z., Holly, J., Gibbs, J. S., Gill, T., Kosikova, M., Li, T., Bakhache, W., Dolan, P. T., Xie, H., Andrews, S. F., Gillespie, R. A., Kanekiyo, M., McDermott, A. B., Pierson, T. C., & Yewdell, J. W. (2024). C1q enables influenza hemagglutinin stem binding antibodies to block viral attachment and broadens the antibody escape repertoire. Science Immunology, 9(93). https://doi.org/10.1126/sciimmunol.adj9534

Vancouver

Kosik I, Da Silva Santos J, Angel M, Hu Z, Holly J, Gibbs JS, et al. C1q enables influenza hemagglutinin stem binding antibodies to block viral attachment and broadens the antibody escape repertoire. Science Immunology. 2024;9(93). doi:10.1126/sciimmunol.adj9534

BibTeX
@article{Kosik2024,
  author = {Kosik, Ivan and Da Silva Santos, Jefferson and Angel, Mathew and Hu, Zhe and Holly, Jaroslav and Gibbs, James S and Gill, Tanner and Kosikova, Martina and Li, Tiansheng and Bakhache, William and Dolan, Patrick T and Xie, Hang and Andrews, Sarah F and Gillespie, Rebecca A and Kanekiyo, Masaru and McDermott, Adrian B and Pierson, Theodore C and Yewdell, Jonathan W},
  title = {C1q enables influenza hemagglutinin stem binding antibodies to block viral attachment and broadens the antibody escape repertoire},
  journal = {Science Immunology},
  year = {2024},
  volume = {9},
  number = {93},
  doi = {10.1126/sciimmunol.adj9534}
}
Kostenlos starten →